文献速递白血病

TIM-3信号劫持经典Wnt/β-catenin通路以维持急性髓系白血病中的肿瘤干性

TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2023-01-01

该研究揭示急性髓系白血病(AML)中由TIM-3与其配体Gal-9组成的自分泌环路不依赖Wnt配体即驱动经典Wnt通路,激活β-catenin以维持白血病干细胞(LSC)自我更新;Gal-9结合TIM-3胞质SH2结构域招募HCK,HCK磷酸化p120-catenin促进LRP6信号体形成;该TIM-3/HCK/p120-catenin轴主要在未成熟LSC中活跃,相关分子有望成为选择性清除LSC而不损伤正常造血干细胞的靶点。

要点

  • AML中TIM-3/Gal-9自分泌环路不依赖Wnt配体即激活经典Wnt通路并维持LSC干性。
  • Gal-9结合TIM-3招募HCK,HCK磷酸化p120-catenin促进LRP6信号体形成以劫持Wnt通路。
  • TIM-3/HCK/p120-catenin轴主要在未成熟LSC中活跃,而非TIM-3阳性的分化AML原始细胞或耗竭T细胞。

核心结论

  • 人AML的LSC通过自分泌TIM-3/HCK/p120-catenin信号组成性激活β-catenin,该信号轴相关分子应成为选择性清除LSC而不损伤正常HSC的关键靶点。

研究设计与样本

  • 本研究为实验研究,原文未报告样本量、分组及具体实验方法细节。

主要发现

  • AML特异性自分泌环路由TIM-3与其配体Gal-9组成,不依赖Wnt配体即驱动经典Wnt通路以刺激LSC自我更新和扩增。
  • Gal-9结合激活TIM-3胞质Src同源2结构域,招募在LSC高表达而在HSC不表达的Src家族激酶HCK。
  • HCK磷酸化p120-catenin,促进LDL受体相关蛋白6(LRP6)信号体形成,从而劫持经典Wnt通路。
  • 该TIM-3/HCK/p120-catenin轴主要在未成熟LSC中活跃,与表达TIM-3的分化AML原始细胞及耗竭T细胞相比更为主要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The activation of β-catenin plays critical roles in normal stem cell function, and, when aberrantly activated, the maintenance and enhancement of cancer stemness in many solid cancers. Aberrant β-catenin activation is also observed in acute myeloid leukemia (AML), and crucially contributes to self-renewal and propagation of leukemic stem cells (LSCs) regardless of mutations in contrast with such solid tumors. In this study, we showed that the AML-specific autocrine loop comprised of T-cell immunoglobulin mucin-3 (TIM-3) and its ligand, galectin-9 (Gal-9), drives the canonical Wnt pathway to stimulate self-renewal and propagation of LSCs, independent of Wnt ligands. Gal-9 ligation activates the cytoplasmic Src homology 2 domain of TIM-3 to recruit hematopoietic cell kinase (HCK), a Src family kinase highly expressed in LSCs but not in HSCs, and HCK phosphorylates p120-catenin to promote formation of the LDL receptor-related protein 6 (LRP6) signalosome, hijacking the canonical Wnt pathway. This TIM-3/HCK/p120-catenin axis is principally active in immature LSCs compared with TIM-3-expressed differentiated AML blasts and exhausted T cells. These data suggest that human AML LSCs constitutively activates β-catenin via autocrine TIM-3/HCK/p120-catenin signaling, and that molecules related to this signaling axis should be critical targets for selective eradication of LSCs without impairing normal HSCs.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Sakoda T, Kikushige Y, Miyamoto T, et al. TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia. Blood Adv. 2023. PMID: 36745103. doi:10.1182/bloodadvances.2022008405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。